Rivaroxaban

  • Référence produit : C2138
  • Numéro de CAS : 366789-02-8
  • Formule moléculaire : C19H18ClN3O5S
  • Masse molaire : 435,88 g.mol-1
  • Pureté min. : 98,00 %
  • Solubilité : se référer au COA

  • Stabilité : ≥ 1 an
  • Expédition : 24/48h pour les produits en stock
Demander un devis
Référence du produit : C2138
Masse
Qté

Description

Rivaroxaban is intended for Pharmaceuticals applications. Rivaroxaban is an orally active, direct inhibitor of Factor Xa and a novel antithrombotic agent. All information about Rivaroxaban is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. Connect to your member account to consult the documents.

Références

  1. [...]
  2. Efficacy of pro- and anticoagulant strategies in plasma of patients undergoing hepatobiliary surgery J Thromb Haemost. 2020;18:2840–2851 [...]
  3. Invasive Infections with Nannizziopsis obscura Species Complex in 9 Patients from West Africa, France, 2004–20201 Emerg Infect Dis. 2020 Sep; 26(9): 2022–2030 [...]
  4. "A UHPLC-MS/MS method to simultaneously quantify apixaban, edoxaban and rivaroxaban in human plasma and breast milk: For emerging lactation studies Journal of Chromatography B Volume 1144, 1 May 2020, 122095" [...]
  5. In vitro assessment of P-gp and BCRP transporter-mediated drug–drug interactions of riociguat with direct oral anticoagulants fundamental & clinical pharmacology, volume 34, issue 1, February 2020, p. 109-119 [...]
  6. Value of quantifying ABC transporters by mass spectrometry and impact on in vitro-to-in vivo prediction of transporter-mediated drug-drug interactions of rivaroxaban European Journal of Pharmaceutics and Biopharmaceutics Volume 148, March 2020, Pages 27-37 [...]

Recommandation